Meeting
2018 Gastrointestinal Cancers Symposium
Postoperative chemotherapy in patients who are pN+ following neoadjuvant chemoradiation for locally advanced esophageal cancer.
Authors
Samual Francis
University of Utah School of Medicine, Salt Lake City, UT
Samual Francis , Christopher Duane Nevala-Plagemann , Courtney Christine Cavalieri , Shane Lloyd , Ignacio Garrido-Laguna
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 36, 2018 (suppl 4S; abstr 97)
DOI
10.1200/JCO.2018.36.4_suppl.97
Abstract #
97
Poster Bd #
H1
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Gastrointestinal Cancers Symposium
Locally advanced esophageal cancer: Evaluation of prognosis by assessment of the “yp” stage based on the neoadjuvant regimen received.
First Author: Indika Gunadasa
Poster
2018 Gastrointestinal Cancers Symposium
The effect of adjuvant chemotherapy in patients without local nodal metastases following neoadjuvant chemoradiotherapy and esophagectomy for locally advanced esophageal cancer.
First Author: Christopher Duane Nevala-Plagemann
Poster
2016 Gastrointestinal Cancers Symposium
Role of adjuvant chemotherapy in locally advanced rectal cancer with ypT0-3N0 after neoadjuvant chemoradiation therapy.
First Author: Chang-gon Kim
Poster
2021 ASCO Annual Meeting
Total neoadjuvant treatment versus standard chemoradiation to increase the sphincter preservation rate for distal locally advanced rectal cancer (TESS).
First Author: Weiwei Xiao